1. Home
  2. Africa
  3. Southern Africa
  4. Mozambique
  • News

Brazil to help build ARV factory

A Brazilian delegation will visit Mozambique this month to finalise plans for building a factory to produce generic antiretroviral drugs.

Mozambican health minister Francisco Songane was reported as saying that the project will benefit not only Mozambique, but also neighbouring countries who will benefit from the drugs.

The initiative follows Brazilian President Luiz Inacio Lula da Silva's visit to Mozambique last year, during which he promised his government would start mobilising funds immediately for the US $20 million factory.

With a population of 17 million, Mozambique has an adult HIV prevalence rate of 16 percent and approximately 700 new infections daily.


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article
Join the discussion

Help make quality journalism about crises possible

The New Humanitarian is an independent, non-profit newsroom founded in 1995. We deliver quality, reliable journalism about crises and big issues impacting the world today. Our reporting on humanitarian aid has uncovered sex scandals, scams, data breaches, corruption, and much more.

 

Our readers trust us to hold power in the multi-billion-dollar aid sector accountable and to amplify the voices of those impacted by crises. We’re on the ground, reporting from the front lines, to bring you the inside story. 

 

We keep our journalism free – no paywalls – thanks to the support of donors and readers like you who believe we need more independent journalism in the world. Your contribution means we can continue delivering award-winning journalism about crises. Become a member of The New Humanitarian today

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join